IMV News and Press, IMV Inc. From 05/15/20

Phase 2 SPiReL study of DPX-Survivac combination regimen with Keytruda® in r/r DLBCL successfully reached primary efficacy endpoint with 64% (7/11) of evaluable patients demonstrating a clinical response Translational and updated clinical response data from Phase 2 DeCidE1 st...

IMV Inc. (“IMV” or the “Company”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines to fight against infectious diseases including COVID-19, today announced that it has completed its ...

IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines to fight against infectious diseases including COVID-19, announced today that it will hold a co...

IMV (NASDAQ: IMV ) announces the private placement of ~7.8M Units at C$2.86 per unit to a group of investors co-led by Fonds de Solidarité FTQ (C$7.5M) and Altium Capital. More news on: IMV Inc., Healthcare stocks news, , Stocks on the move, Read more ...

Vaccine Candidate to Prevent COVID-19: Fonds de solidarité FTQ to Invest $7.5 Million in IMV Canada NewsWire QUÉBEC CITY, April 30, 2020 QUÉBEC CITY, April 30, 2020 /CNW Telbec/ - The Fonds de solidarité FTQ (the "Fonds" will invest $7.5 mi...

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company, today announced its intention to complete a private placement (the “Private Placement”) of 7,797,203 units of the Company (each, a “Unit”) at the market price of Cdn$2.86 per Unit based o...

IMV Inc. (Nasdaq: IMV; TSX: IMV) a clinical-stage biopharmaceutical company, today announced that Company’s management will be participating in Adelaide Capital’s Virtual COVID & Healthcare Mini Conference on April 23, 2020 from 12pm-5pm ET. The conference will showcas...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

IMV, Inc. (IMV) Q4 2019 Results Earnings Conference Call March 31, 2020, 08:00 AM ET Company Participants Pierre Labbé - Chief Financial Officer Frederic Ors - Chief Executive Officer Joanne Schindler - Chief Medical Officer Marianne Stanford - Vice President, Research and...

Launched development program for a DPX-based vaccine candidate against COVID-19 Reported updated Phase 2 data from DeCidE1 study in advanced ovarian cancer; These encouraging results support DPX-Survivac being amongst the first in vivo T cell therapy to demonstrate meaningful cli...